Rx Bandz, LLC — Department of Defense SBIR Phase I: X224-OCSO1

Rx Bandz, LLC — SBIR Phase I award from Department of Defense.

Amount
$74,982
Agency
Department of Defense · Air Force
Program / Phase
SBIR · Phase I
Topic
X224-OCSO1
Solicitation
X22.4
NAICS
Place of performance
TX
Period
2022-11-03 → 2023-02-04

Description

Epinephrine and other medications are  sensitive to oxygen.  When the compounds comes in contact with Oxygen, which is unpreventable, the compound starts to degrade.  SMS is commonly used as a preservative to reduce oxygenation. However, it is impossible to prevent the leak of oxygen into the epinephrine within an auto-injector or prefilled syringe.  Even small amounts of oxygen over time cause degradation of the epinephrine.  Rx Bandz proposes adding SMS, a oxygen- reducing agent in the hydraulic fluid.  This will allow manufacturers to  to reduce the amount of  sms in the commonly used 1 mg in cartridge extends from 4-5 months in the customer’s hands (after manufacture, storage and shipping) to 18 months.